Clinical Trial Update: Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence trial comparing GR37547 500 mg tablet to ciprofloxacin 500 mg in healthy adults; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Bacterial

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• GR37547

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED | Results posted: 2018-12-19